Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

April 01, 2023; Volume 385,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abbas, Atheir I.

    1. You have access
      Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
      Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, Shelley H. Bloom, Katherine M. Wolfrum, Jennifer L. Schmachtenberg, Randall J. Olson, Aaron Janowsky and Atheir I. Abbas
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 62-75; DOI: https://doi.org/10.1124/jpet.122.001454
  2. Abbruscato, Thomas J.

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384
  3. Abuduwaili, Halimulati

    1. You have access
      Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes
      Kyoko Kamoshita, Kiyo-aki Ishii, Yumiko Tahira, Akihiro Kikuchi, Halimulati Abuduwaili, Natsumi Tajima-Shirasaki, Qifang Li, Hiroaki Takayama, Kunio Matsumoto and Toshinari Takamura
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 5-16; DOI: https://doi.org/10.1124/jpet.122.001088
  4. Akwii, Racheal G.

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384
  5. Al-Ahmad, Abraham

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384
  6. Arnold, Leggy A.

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362
  7. Astrinidis, Aristotelis

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384

B

  1. Bickel, Ulrich

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384
  2. Bloom, Shelley H.

    1. You have access
      Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
      Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, Shelley H. Bloom, Katherine M. Wolfrum, Jennifer L. Schmachtenberg, Randall J. Olson, Aaron Janowsky and Atheir I. Abbas
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 62-75; DOI: https://doi.org/10.1124/jpet.122.001454

C

  1. Cerne, Rok

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362
  2. Cook, James M.

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362

D

  1. Divović, Branka

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362

E

  1. Eshleman, Amy J.

    1. You have access
      Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
      Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, Shelley H. Bloom, Katherine M. Wolfrum, Jennifer L. Schmachtenberg, Randall J. Olson, Aaron Janowsky and Atheir I. Abbas
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 62-75; DOI: https://doi.org/10.1124/jpet.122.001454

G

  1. German, Nadezhda A.

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384
  2. Golani, Lalit K.

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362
  3. Guindon, Josée

    1. You have access
      Cannabinoid Tolerance in S426A/S430A x β-Arrestin 2 Knockout Double-Mutant Mice
      Mary K. Piscura, Diana E. Sepulveda, Malabika Maulik, Josée Guindon, Angela N. Henderson-Redmond and Daniel J. Morgan
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 17-34; DOI: https://doi.org/10.1124/jpet.122.001367

H

  1. Henderson-Redmond, Angela N.

    1. You have access
      Cannabinoid Tolerance in S426A/S430A x β-Arrestin 2 Knockout Double-Mutant Mice
      Mary K. Piscura, Diana E. Sepulveda, Malabika Maulik, Josée Guindon, Angela N. Henderson-Redmond and Daniel J. Morgan
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 17-34; DOI: https://doi.org/10.1124/jpet.122.001367

I

  1. Ishii, Kiyo-aki

    1. You have access
      Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes
      Kyoko Kamoshita, Kiyo-aki Ishii, Yumiko Tahira, Akihiro Kikuchi, Halimulati Abuduwaili, Natsumi Tajima-Shirasaki, Qifang Li, Hiroaki Takayama, Kunio Matsumoto and Toshinari Takamura
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 5-16; DOI: https://doi.org/10.1124/jpet.122.001088

J

  1. Janowsky, Aaron

    1. You have access
      Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
      Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, Shelley H. Bloom, Katherine M. Wolfrum, Jennifer L. Schmachtenberg, Randall J. Olson, Aaron Janowsky and Atheir I. Abbas
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 62-75; DOI: https://doi.org/10.1124/jpet.122.001454
  2. Jin, Xiaoming

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362

K

  1. Kamoshita, Kyoko

    1. You have access
      Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes
      Kyoko Kamoshita, Kiyo-aki Ishii, Yumiko Tahira, Akihiro Kikuchi, Halimulati Abuduwaili, Natsumi Tajima-Shirasaki, Qifang Li, Hiroaki Takayama, Kunio Matsumoto and Toshinari Takamura
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 5-16; DOI: https://doi.org/10.1124/jpet.122.001088
  2. Kikuchi, Akihiro

    1. You have access
      Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes
      Kyoko Kamoshita, Kiyo-aki Ishii, Yumiko Tahira, Akihiro Kikuchi, Halimulati Abuduwaili, Natsumi Tajima-Shirasaki, Qifang Li, Hiroaki Takayama, Kunio Matsumoto and Toshinari Takamura
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 5-16; DOI: https://doi.org/10.1124/jpet.122.001088
  3. Kozell, Laura B.

    1. You have access
      Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
      Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, Shelley H. Bloom, Katherine M. Wolfrum, Jennifer L. Schmachtenberg, Randall J. Olson, Aaron Janowsky and Atheir I. Abbas
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 62-75; DOI: https://doi.org/10.1124/jpet.122.001454

L

  1. Lahooti, Behnaz

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384
  2. Lamprou, Margarita

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384
  3. Li, Qifang

    1. You have access
      Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes
      Kyoko Kamoshita, Kiyo-aki Ishii, Yumiko Tahira, Akihiro Kikuchi, Halimulati Abuduwaili, Natsumi Tajima-Shirasaki, Qifang Li, Hiroaki Takayama, Kunio Matsumoto and Toshinari Takamura
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 5-16; DOI: https://doi.org/10.1124/jpet.122.001088
  4. Lippa, Arnold

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362

M

  1. Madadi, Mahboubeh

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384
  2. Matsumoto, Kunio

    1. You have access
      Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes
      Kyoko Kamoshita, Kiyo-aki Ishii, Yumiko Tahira, Akihiro Kikuchi, Halimulati Abuduwaili, Natsumi Tajima-Shirasaki, Qifang Li, Hiroaki Takayama, Kunio Matsumoto and Toshinari Takamura
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 5-16; DOI: https://doi.org/10.1124/jpet.122.001088
  3. Mattheolabakis, George

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384
  4. Maulik, Malabika

    1. You have access
      Cannabinoid Tolerance in S426A/S430A x β-Arrestin 2 Knockout Double-Mutant Mice
      Mary K. Piscura, Diana E. Sepulveda, Malabika Maulik, Josée Guindon, Angela N. Henderson-Redmond and Daniel J. Morgan
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 17-34; DOI: https://doi.org/10.1124/jpet.122.001367
  5. Meyer, Michelle Jean

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362
  6. Mian, Md Yeunus

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362
  7. Mikelis, Constantinos M.

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384
  8. Morgan, Daniel J.

    1. You have access
      Cannabinoid Tolerance in S426A/S430A x β-Arrestin 2 Knockout Double-Mutant Mice
      Mary K. Piscura, Diana E. Sepulveda, Malabika Maulik, Josée Guindon, Angela N. Henderson-Redmond and Daniel J. Morgan
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 17-34; DOI: https://doi.org/10.1124/jpet.122.001367
  9. Morrow, Nadya M.

    1. You have access
      Complexity in Hepatic Insulin Resistance – Unraveling the Role of Ubiquitin-Specific Protease 14 in Protein Homeostasis of Metabolic Transcription Factors
      Nadya M. Morrow and Erin E. Mulvihill
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 1-4; DOI: https://doi.org/10.1124/jpet.122.001517
  10. Mulvihill, Erin E.

    1. You have access
      Complexity in Hepatic Insulin Resistance – Unraveling the Role of Ubiquitin-Specific Protease 14 in Protein Homeostasis of Metabolic Transcription Factors
      Nadya M. Morrow and Erin E. Mulvihill
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 1-4; DOI: https://doi.org/10.1124/jpet.122.001517

O

  1. Olson, Randall J.

    1. You have access
      Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
      Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, Shelley H. Bloom, Katherine M. Wolfrum, Jennifer L. Schmachtenberg, Randall J. Olson, Aaron Janowsky and Atheir I. Abbas
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 62-75; DOI: https://doi.org/10.1124/jpet.122.001454

P

  1. Pandey, Kamal P.

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362
  2. Patel, Dhavalkumar

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384
  3. Ping, Xingjie

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362
  4. Piscura, Mary K.

    1. You have access
      Cannabinoid Tolerance in S426A/S430A x β-Arrestin 2 Knockout Double-Mutant Mice
      Mary K. Piscura, Diana E. Sepulveda, Malabika Maulik, Josée Guindon, Angela N. Henderson-Redmond and Daniel J. Morgan
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 17-34; DOI: https://doi.org/10.1124/jpet.122.001367

R

  1. Rashid, Farjana

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362

S

  1. Savić, Miroslav M.

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362
  2. Schmachtenberg, Jennifer L.

    1. You have access
      Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
      Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, Shelley H. Bloom, Katherine M. Wolfrum, Jennifer L. Schmachtenberg, Randall J. Olson, Aaron Janowsky and Atheir I. Abbas
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 62-75; DOI: https://doi.org/10.1124/jpet.122.001454
  3. Sepulveda, Diana E.

    1. You have access
      Cannabinoid Tolerance in S426A/S430A x β-Arrestin 2 Knockout Double-Mutant Mice
      Mary K. Piscura, Diana E. Sepulveda, Malabika Maulik, Josée Guindon, Angela N. Henderson-Redmond and Daniel J. Morgan
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 17-34; DOI: https://doi.org/10.1124/jpet.122.001367
  4. ShahbaziNia, Siavash

    1. You have access
      Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
      Behnaz Lahooti, Racheal G. Akwii, Dhavalkumar Patel, Siavash ShahbaziNia, Margarita Lamprou, Mahboubeh Madadi, Thomas J. Abbruscato, Aristotelis Astrinidis, Ulrich Bickel, Abraham Al-Ahmad, Nadezhda A. German, George Mattheolabakis and Constantinos M. Mikelis
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 35-49; DOI: https://doi.org/10.1124/jpet.122.001384
  5. Sharmin, Dishary

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362
  6. Smith, Jodi L.

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362
  7. Swanson, Tracy L.

    1. You have access
      Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
      Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, Shelley H. Bloom, Katherine M. Wolfrum, Jennifer L. Schmachtenberg, Randall J. Olson, Aaron Janowsky and Atheir I. Abbas
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 62-75; DOI: https://doi.org/10.1124/jpet.122.001454

T

  1. Tahira, Yumiko

    1. You have access
      Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes
      Kyoko Kamoshita, Kiyo-aki Ishii, Yumiko Tahira, Akihiro Kikuchi, Halimulati Abuduwaili, Natsumi Tajima-Shirasaki, Qifang Li, Hiroaki Takayama, Kunio Matsumoto and Toshinari Takamura
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 5-16; DOI: https://doi.org/10.1124/jpet.122.001088
  2. Tajima-Shirasaki, Natsumi

    1. You have access
      Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes
      Kyoko Kamoshita, Kiyo-aki Ishii, Yumiko Tahira, Akihiro Kikuchi, Halimulati Abuduwaili, Natsumi Tajima-Shirasaki, Qifang Li, Hiroaki Takayama, Kunio Matsumoto and Toshinari Takamura
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 5-16; DOI: https://doi.org/10.1124/jpet.122.001088
  3. Takamura, Toshinari

    1. You have access
      Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes
      Kyoko Kamoshita, Kiyo-aki Ishii, Yumiko Tahira, Akihiro Kikuchi, Halimulati Abuduwaili, Natsumi Tajima-Shirasaki, Qifang Li, Hiroaki Takayama, Kunio Matsumoto and Toshinari Takamura
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 5-16; DOI: https://doi.org/10.1124/jpet.122.001088
  4. Takayama, Hiroaki

    1. You have access
      Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes
      Kyoko Kamoshita, Kiyo-aki Ishii, Yumiko Tahira, Akihiro Kikuchi, Halimulati Abuduwaili, Natsumi Tajima-Shirasaki, Qifang Li, Hiroaki Takayama, Kunio Matsumoto and Toshinari Takamura
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 5-16; DOI: https://doi.org/10.1124/jpet.122.001088
  5. Tiruveedhula, V.V.N. Phani Babu

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362

W

  1. Witkin, Jeffrey M.

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362
  2. Wolfrum, Katherine M.

    1. You have access
      Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
      Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, Shelley H. Bloom, Katherine M. Wolfrum, Jennifer L. Schmachtenberg, Randall J. Olson, Aaron Janowsky and Atheir I. Abbas
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 62-75; DOI: https://doi.org/10.1124/jpet.122.001454

Z

  1. Zahn, Nicolas M.

    1. You have access
      Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
      Kamal P. Pandey, Branka Divović, Farjana Rashid, Lalit K. Golani, Rok Cerne, Nicolas M. Zahn, Michelle Jean Meyer, Leggy A. Arnold, Dishary Sharmin, Md Yeunus Mian, Jodi L. Smith, Xingjie Ping, Xiaoming Jin, Arnold Lippa, V.V.N. Phani Babu Tiruveedhula, James M. Cook, Miroslav M. Savić and Jeffrey M. Witkin
      Journal of Pharmacology and Experimental Therapeutics April 2023, 385 (1) 50-61; DOI: https://doi.org/10.1124/jpet.122.001362
Back to top
Previous

In this issue

Journal of Pharmacology and Experimental Therapeutics: 385 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 385, Issue 1
1 Apr 2023
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics